| 7NT | Name: | ~{N}-(4-morpholin-4-ylthieno[2,3-d]pyrimidin-2-yl)propanamide | Formula: | C13 H16 N4 O2 S | SMILES: | CCC(=O)Nc1nc2sccc2c(n1)N3CCOCC3 | InChi: | InChI=1S/C13H16N4O2S/c1-2-10(18)14-13-15-11(17-4-6-19-7-5-17)9-3-8-20-12(9)16-13/h3,8H,2,4-7H2,1H3,(H,14,15,16,18) | Definition date: | 2016-11-28 | Last modified: | 2024-09-27 | Release date: | 2017-11-01 | Identifier: | ~{N}-(4-morpholin-4-ylthieno[2,3-d]pyrimidin-2-yl)propanamide |
|
| NLW | Name: | L-leucinamide | Formula: | C6 H14 N2 O | SMILES: | CC(CC(C(N)=O)N)C | InChi: | InChI=1S/C6H14N2O/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H2,8,9)/t5-/m0/s1 | Definition date: | 2016-03-22 | Last modified: | 2024-09-27 | Release date: | 2016-08-03 | Identifier: | L-leucinamide |
|
| 7NW | Name: | 2-methyl-1,3-thiazole-4-carboxylic acid | Formula: | C5 H5 N O2 S | SMILES: | Cc1scc(n1)C(O)=O | InChi: | InChI=1S/C5H5NO2S/c1-3-6-4(2-9-3)5(7)8/h2H,1H3,(H,7,8) | Definition date: | 2016-11-29 | Last modified: | 2024-09-27 | Release date: | 2017-12-20 | Identifier: | 2-methyl-1,3-thiazole-4-carboxylic acid |
|
| NLY | Name: | N-(4-aminobutyl)glycine | Formula: | C6 H14 N2 O2 | SMILES: | O=C(O)CNCCCCN | InChi: | InChI=1S/C6H14N2O2/c7-3-1-2-4-8-5-6(9)10/h8H,1-5,7H2,(H,9,10) | Definition date: | 2012-10-18 | Last modified: | 2024-09-27 | Release date: | 2013-10-09 | Identifier: | N-(4-aminobutyl)glycine |
|
| 7NX | Name: | cyclohexylmethyl hydrogen carbonate | Formula: | C8 H14 O3 | SMILES: | OC(=O)OCC1CCCCC1 | InChi: | InChI=1S/C8H14O3/c9-8(10)11-6-7-4-2-1-3-5-7/h7H,1-6H2,(H,9,10) | Definition date: | 2016-11-29 | Last modified: | 2024-09-27 | Release date: | 2017-12-20 | Identifier: | cyclohexylmethyl hydrogen carbonate |
|
| 7O3 | Name: | 2-chloranyl-~{N}-[4-[(2-chloranyl-5-oxidanyl-phenyl)amino]quinazolin-7-yl]ethanamide | Formula: | C16 H12 Cl2 N4 O2 | SMILES: | Oc1ccc(Cl)c(Nc2ncnc3cc(NC(=O)CCl)ccc23)c1 | InChi: | InChI=1S/C16H12Cl2N4O2/c17-7-15(24)21-9-1-3-11-13(5-9)19-8-20-16(11)22-14-6-10(23)2-4-12(14)18/h1-6,8,23H,7H2,(H,21,24)(H,19,20,22) | Definition date: | 2016-12-01 | Last modified: | 2024-09-27 | Release date: | 2017-05-17 | Identifier: | 2-chloranyl-~{N}-[4-[(2-chloranyl-5-oxidanyl-phenyl)amino]quinazolin-7-yl]ethanamide |
|
| 7O5 | Name: | (2~{S})-2-azanyl-3-(2-sulfanylethanoylamino)propanoic acid | Formula: | C5 H10 N2 O3 S | SMILES: | N[CH](CNC(=O)CS)C(O)=O | InChi: | InChI=1S/C5H10N2O3S/c6-3(5(9)10)1-7-4(8)2-11/h3,11H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1 | Definition date: | 2016-12-01 | Last modified: | 2024-09-27 | Release date: | 2020-05-27 | Identifier: | (2~{S})-2-azanyl-3-(2-sulfanylethanoylamino)propanoic acid |
|
| NMC | Name: | N-CYCLOPROPYLMETHYL GLYCINE | Formula: | C6 H11 N O2 | SMILES: | O=C(O)CNCC1CC1 | InChi: | InChI=1S/C6H11NO2/c8-6(9)4-7-3-5-1-2-5/h5,7H,1-4H2,(H,8,9) | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N-(cyclopropylmethyl)glycine |
|
| NME | Name: | METHYLAMINE | Formula: | C H5 N | SMILES: | NC | InChi: | InChI=1S/CH5N/c1-2/h2H2,1H3 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | methanamine |
|
| NMI | Name: | 3-(1-methyl-1H-indol-3-yl)propanoic acid | Formula: | C12 H13 N O2 | SMILES: | O=C(O)CCc2c1ccccc1n(c2)C | InChi: | InChI=1S/C12H13NO2/c1-13-8-9(6-7-12(14)15)10-4-2-3-5-11(10)13/h2-5,8H,6-7H2,1H3,(H,14,15) | Definition date: | 2014-04-07 | Last modified: | 2024-09-27 | Release date: | 2014-06-18 | Identifier: | 3-(1-methyl-1H-indol-3-yl)propanoic acid |
|
| NMK | Name: | N-methyl Lysine | Formula: | C7 H17 N2 O2 | SMILES: | CN[CH](CCCC[NH3+])C(O)=O | InChi: | InChI=1S/C7H16N2O2/c1-9-6(7(10)11)4-2-3-5-8/h6,9H,2-5,8H2,1H3,(H,10,11)/p+1/t6-/m0/s1 | Definition date: | 2018-10-10 | Last modified: | 2024-09-27 | Release date: | 2019-01-16 | Identifier: | [(5~{S})-5-(methylamino)-6-oxidanyl-6-oxidanylidene-hexyl]azanium |
|
| NML | Name: | N-METHYLACETAMIDE | Formula: | C3 H7 N O | SMILES: | O=C(NC)C | InChi: | InChI=1S/C3H7NO/c1-3(5)4-2/h1-2H3,(H,4,5) | Definition date: | 2006-10-27 | Last modified: | 2024-09-27 | Identifier: | N-methylacetamide |
|
| NMM | Name: | (2S)-2-amino-5-[(N-methylcarbamimidoyl)amino]pentanoic acid | Formula: | C7 H16 N4 O2 | SMILES: | O=C(O)C(N)CCCNC(=[N@H])NC | InChi: | InChI=1S/C7H16N4O2/c1-10-7(9)11-4-2-3-5(8)6(12)13/h5H,2-4,8H2,1H3,(H,12,13)(H3,9,10,11)/t5-/m0/s1 | Synonyms: | L-NMMA | Definition date: | 2005-12-28 | Last modified: | 2024-09-27 | Identifier: | N~5~-(N-methylcarbamimidoyl)-L-ornithine |
|
| 7ON | Name: | (3~{S},3~{a}~{S},6~{a}~{R})-2-[(2~{S})-2-cyclohexyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]ethanoyl]-~{N}-[(2~{S})-4-(cyclopentylamino)-3,4-bis(oxidanylidene)-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]butan-2-yl]-3,3~{a},4,5,6,6~{a}-hexahydro-1~{H}-cyclopenta[c]pyrrole-3-carboxamide | Formula: | C31 H44 F3 N5 O6 | SMILES: | FC(F)(F)C(=O)N[CH](C1CCCCC1)C(=O)N2C[CH]3CCC[CH]3[CH]2C(=O)N[CH](C[CH]4CCNC4=O)C(=O)C(=O)NC5CCCC5 | InChi: | InChI=1S/C31H44F3N5O6/c32-31(33,34)30(45)38-23(17-7-2-1-3-8-17)29(44)39-16-19-9-6-12-21(19)24(39)27(42)37-22(15-18-13-14-35-26(18)41)25(40)28(43)36-20-10-4-5-11-20/h17-24H,1-16H2,(H,35,41)(H,36,43)(H,37,42)(H,38,45)/t18-,19-,21-,22-,23-,24-/m0/s1 | Definition date: | 2023-03-01 | Last modified: | 2024-09-27 | Release date: | 2023-04-05 | Identifier: | (3~{S},3~{a}~{S},6~{a}~{R})-2-[(2~{S})-2-cyclohexyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]ethanoyl]-~{N}-[(2~{S})-4-(cyclopentylamino)-3,4-bis(oxidanylidene)-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]butan-2-yl]-3,3~{a},4,5,6,6~{a}-hexahydro-1~{H}-cyclopenta[c]pyrrole-3-carboxamide |
|
| NMP | Name: | 2-[2-(2-CYCLOHEXYL-2-GUANIDINO-ACETYLAMINO)-ACETYLAMINO]-N-(3-MERCAPTO-PROPYL)-PROPIONAMIDE | Formula: | C17 H32 N6 O3 S | SMILES: | O=C(NCCCS)C(NC(=O)CNC(=O)C(NC(=[N@H])N)C1CCCCC1)C | InChi: | InChI=1S/C17H32N6O3S/c1-11(15(25)20-8-5-9-27)22-13(24)10-21-16(26)14(23-17(18)19)12-6-3-2-4-7-12/h11-12,14,27H,2-10H2,1H3,(H,20,25)(H,21,26)(H,22,24)(H4,18,19,23)/t11-,14+/m0/s1 | Definition date: | 2002-07-09 | Last modified: | 2024-09-27 | Identifier: | N-[(2R)-2-carbamimidamido-2-cyclohexylacetyl]glycyl-N-(3-sulfanylpropyl)-L-alaninamide |
|
| 7OZ | Name: | (S)-2-amino-4-fluorobutanoic acid | Formula: | C4 H8 F N O2 | SMILES: | N[CH](CCF)C(O)=O | InChi: | InChI=1S/C4H8FNO2/c5-2-1-3(6)4(7)8/h3H,1-2,6H2,(H,7,8)/t3-/m0/s1 | Synonyms: | (2S)-2-azanyl-4-fluoranyl-butanoic acid | Definition date: | 2021-08-16 | Last modified: | 2024-09-27 | Release date: | 2022-03-09 | Identifier: | (2~{S})-2-azanyl-4-fluoranyl-butanoic acid |
|
| 7P6 | Name: | [(2R,3S,4R,5R)-3,4,5-tris(oxidanyl)oxan-2-yl]methyl dihydrogen phosphate | Formula: | C6 H13 O8 P | SMILES: | O[CH]1CO[CH](CO[P](O)(O)=O)[CH](O)[CH]1O | InChi: | InChI=1S/C6H13O8P/c7-3-1-13-4(6(9)5(3)8)2-14-15(10,11)12/h3-9H,1-2H2,(H2,10,11,12)/t3-,4-,5-,6-/m1/s1 | Definition date: | 2023-03-02 | Last modified: | 2024-09-27 | Release date: | 2024-10-02 | Identifier: | [(2~{R},3~{S},4~{R},5~{R})-3,4,5-tris(oxidanyl)oxan-2-yl]methyl dihydrogen phosphate |
|
| NNA | Name: | (1R,2S,5S)-3-[N-({1-[(tert-butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-methyl-L-valyl]-N-{(1S)-1-[(1R)-2-(cyclopropylamino)-1-hydroxy-2-oxoethyl]pentyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide | Formula: | C36 H63 N5 O7 S | SMILES: | O=C(N3C(C(=O)NC(CCCC)C(O)C(=O)NC1CC1)C2C(C)(C2C3)C)C(NC(=O)NC4(CS(=O)(=O)C(C)(C)C)CCCCC4)C(C)(C)C | InChi: | InChI=1S/C36H63N5O7S/c1-10-11-15-24(27(42)30(44)37-22-16-17-22)38-29(43)26-25-23(35(25,8)9)20-41(26)31(45)28(33(2,3)4)39-32(46)40-36(18-13-12-14-19-36)21-49(47,48)34(5,6)7/h22-28,42H,10-21H2,1-9H3,(H,37,44)(H,38,43)(H2,39,40,46)/t23-,24-,25-,26-,27+,28+/m0/s1 | Synonyms: | Narlaprevir, bound form | Definition date: | 2010-03-09 | Last modified: | 2024-09-27 | Identifier: | (1R,2S,5S)-3-[N-({1-[(tert-butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-methyl-L-valyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxoheptan-3-yl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide |
|
| 7PO | Name: | hexacosanoic acid | Formula: | C26 H52 O2 | SMILES: | CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O | InChi: | InChI=1S/C26H52O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26(27)28/h2-25H2,1H3,(H,27,28) | Definition date: | 2022-02-22 | Last modified: | 2024-09-27 | Release date: | 2023-03-22 | Identifier: | hexacosanoic acid |
|
| NO | Name: | NITRIC OXIDE | Formula: | N O | SMILES: | [N]=O | InChi: | InChI=1S/HNO/c1-2/h1H | Synonyms: | Nitrogen monoxide | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | nitric oxide |
|
| NO1 | Name: | 4-(hydroxymethyl)-3-methyl-1H-indole-2-carboxylic acid | Formula: | C11 H11 N O3 | SMILES: | O=C(O)c2c(c1c(cccc1n2)CO)C | InChi: | InChI=1S/C11H11NO3/c1-6-9-7(5-13)3-2-4-8(9)12-10(6)11(14)15/h2-4,12-13H,5H2,1H3,(H,14,15) | Definition date: | 2010-11-03 | Last modified: | 2024-09-27 | Identifier: | 4-(hydroxymethyl)-3-methyl-1H-indole-2-carboxylic acid |
|
| NO3 | Name: | NITRATE ION | Formula: | N O3 | SMILES: | [O-][N+]([O-])=O | InChi: | InChI=1S/NO3/c2-1(3)4/q-1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | nitrate |
|
| NO6 | Name: | S-[(pyridin-2-yl)methyl]-L-cysteine | Formula: | C9 H12 N2 O2 S | SMILES: | O=C(O)C(N)CSCc1ccccn1 | InChi: | InChI=1S/C9H12N2O2S/c10-8(9(12)13)6-14-5-7-3-1-2-4-11-7/h1-4,8H,5-6,10H2,(H,12,13)/t8-/m0/s1 | Definition date: | 2022-04-06 | Last modified: | 2024-09-27 | Release date: | 2023-08-30 | Identifier: | S-[(pyridin-2-yl)methyl]-L-cysteine |
|
| 7QK | Name: | N~6~-acetyl-N~6~-methyl-L-lysine | Formula: | C9 H18 N2 O3 | SMILES: | NC(CCCCN(C)C(C)=O)C(=O)O | InChi: | InChI=1S/C9H18N2O3/c1-7(12)11(2)6-4-3-5-8(10)9(13)14/h8H,3-6,10H2,1-2H3,(H,13,14)/t8-/m0/s1 | Definition date: | 2021-08-17 | Last modified: | 2024-09-27 | Release date: | 2023-07-26 | Identifier: | N~6~-acetyl-N~6~-methyl-L-lysine |
|
| NOL | Name: | N-[(BENZYLOXY)CARBONYL]-O-(TERT-BUTYL)-L-THREONYL-3-CYCLOHEXYL-N-[(1S)-2-HYDROXY-1-{[(3S)-2-OXOPYRROLIDIN-3-YL]METHYL}ETHYL]-L-ALANINAMIDE | Formula: | C32 H50 N4 O7 | SMILES: | O=C(OCc1ccccc1)NC(C(=O)NC(C(=O)NC(CC2C(=O)NCC2)CO)CC3CCCCC3)C(OC(C)(C)C)C | InChi: | InChI=1S/C32H50N4O7/c1-21(43-32(2,3)4)27(36-31(41)42-20-23-13-9-6-10-14-23)30(40)35-26(17-22-11-7-5-8-12-22)29(39)34-25(19-37)18-24-15-16-33-28(24)38/h6,9-10,13-14,21-22,24-27,37H,5,7-8,11-12,15-20H2,1-4H3,(H,33,38)(H,34,39)(H,35,40)(H,36,41)/t21-,24+,25+,26+,27+/m1/s1 | Definition date: | 2006-06-14 | Last modified: | 2024-09-27 | Identifier: | N-[(benzyloxy)carbonyl]-O-tert-butyl-L-threonyl-3-cyclohexyl-N-[(1S)-2-hydroxy-1-{[(3S)-2-oxopyrrolidin-3-yl]methyl}ethyl]-L-alaninamide |
|